Hangzhou (1)

Stage IV Esophagus Squamous Cell Carcinoma (1)

Not yet recruiting (1)

phase 2 (1)

Zhejiang Cancer Hospital (1)

anlotinib (1)

camrelizumab (1)

docetaxel (1)

irinotecan (1)

paclitaxel (1)

paclitaxel-albumin (1)

drug (1)

Other (1)

Interventional (1)

stage iv esophagus squamous cell carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Apr 2, 2022